Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation by Vöhringer, Matthias et al.




© 2010 Vöhringer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research Oxygenation-sensitive CMR for assessing 
vasodilator-induced changes of myocardial 
oxygenation
Matthias Vöhringer1,2, Jacqueline A Flewitt1, Jordin D Green1,3, Rohan Dharmakumar4, Jiun Wang Jr5, John V Tyberg6 
and Matthias G Friedrich*7
Abstract
Background: As myocardial oxygenation may serve as a marker for ischemia and microvascular dysfunction, it could 
be clinically useful to have a non-invasive measure of changes in myocardial oxygenation. However, the impact of 
induced blood flow changes on oxygenation is not well understood. We used oxygenation-sensitive CMR to assess the 
relations between myocardial oxygenation and coronary sinus blood oxygen saturation (SvO2) and coronary blood 
flow in a dog model in which hyperemia was induced by intracoronary administration of vasodilators.
Results: During administration of acetylcholine and adenosine, CMR signal intensity correlated linearly with 
simultaneously measured SvO2 (r2 = 0.74, P < 0.001). Both SvO2 and CMR signal intensity were exponentially related to 
coronary blood flow, with SvO2 approaching 87%.
Conclusions: Myocardial oxygenation as assessed with oxygenation-sensitive CMR imaging is linearly related to SvO2 
and is exponentially related to vasodilator-induced increases of blood flow. Oxygenation-sensitive CMR may be useful 
to assess ischemia and microvascular function in patients. Its clinical utility should be evaluated.
Background
Myocardial oxygenation, reflecting the balance or imbal-
ance between oxygen demand and supply, is an important
diagnostic target in various clinical settings[1], but may
be especially useful for assessing ischemia and microvas-
cular function. Presently available diagnostic tools are
invasive, use exogenous contrast agents and/or radiation,
are only useful in particular coronary territories, or have
a limited spatial resolution[2,3]. Moreover, they do not
provide direct measures of ischemia.
T2*-sensitive, Blood-Oxygen-Level-Dependent Cardio-
vascular MR (BOLD-CMR) uses the paramagnetic prop-
e r t i e s  o f  d e o x y g e n a t e d  h e m o g l o b i n  a s  a n  e n d o g e n o u s
contrast mechanism and is thus oxygenation-depen-
dent[4]. In oxygenation-sensitive CMR images, the signal
intensity of any soft tissue is inversely correlated with its
absolute content of deoxygenated hemoglobin and is
therefore theoretically sensitive to changes in blood vol-
ume and oxygen supply-demand balance[5]. Such
sequences have been used routinely for functional brain
imaging[6] and similar approaches have been applied to
the heart and peripheral perfusion beds [7-10]. Although
these T2* measurement and T2*-mapping techniques
have been shown to have high BOLD sensitivity, they had
limited clinical use thus far because of long acquisition
times and relatively low signal-to-noise ratios. Addition-
ally, magnetic field inhomogeneities, blood flow and car-
diac motion may all impair image quality.
Recently, BOLD-sensitive, steady-state free precession
(SSFP) techniques with much more consistent image
quality have been introduced [11-13] and applied in
experimental models of coronary artery stenosis[14,15].
To date, however, SSFP BOLD-CMR has not been vali-
dated against simultaneous measurements of myocardial
oxygenation changes. Moreover, BOLD-weighted SSFP
imaging has not been compared against other approaches
such as T2* mapping.
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We hypothesized that SSFP BOLD-CMR can accurately
and consistently detect changes of myocardial oxygen-
ation in vivo.
Methods
We used a canine model with selective intracoronary
vasodilator infusion. In order to cover the full range of
physiological flow changes we applied graded infusions of
the endothelium-dependent vasodilator, acetylcholine, as
well as the endothelium-independent vasodilator, ade-
nosine.
Animal Preparation
Seven mongrel dogs (weight 15 to 25 kg) were studied; all
experiments were conducted in accordance with the most
recent policies and "Guide to the Care and Use of Experi-
mental Animals" by the Canadian Council on Animal
Care. The local animal care and use board approved the
study protocol and sample size.
Under general anesthesia, a midline sternotomy was
performed and a 2-mm MR-compatible flow probe
(Transonic Systems Inc., Ithaca, NY) placed around the
proximal left circumflex (LCX) coronary artery. Under
fluoroscopic control, a 2.7-F infusion catheter (Tracker®-
18 Hi-Flow, Boston Scientific Ltd., Cork, Ireland) was
introduced into the LCX through a diagnostic coronary
catheter (JL 2.5, Torcon NB ® Advantage Catheter, Cook ®,
Denmark). The tip of the infusion catheter was placed a
few millimeters proximal to the flow probe while ensur-
ing that there were no visible side branches located
between the infusion catheter and flow probe. In addi-
tion, a 4-F balloon catheter (Berman Angiographic Bal-
loon Catheter, Arrow, Reading, PA, USA) was introduced
into the coronary sinus (CS) for blood sampling. Blood
gases were analyzed using a portable analyzer (STAT
PROFILE®  Critical Care Xpress, Nova Biomedical,
Waltham, MA, USA). All procedures including the CMR
scan were performed in adjacent rooms with the dogs
being placed on an MR-compatible cradle that allowed
for a quick and easy transport to and from the MR sys-
tem.
CMR Protocol
All CMR scans were performed in a clinical 1.5-T MRI
system (MAGNETOM Avanto®, Siemens Healthcare,
Erlangen, Germany) with a 6-element phased-array coil
resting on the chest and another below the spine. After
acquiring localizer planes and performing manual
regional shimming, BOLD-CMR was performed in a sin-
gle mid-ventricular short-axis view at baseline (BL 1-3)
and during intracoronary vasodilator infusion into the
LCX. Acetylcholine (ACh) was infused in three increas-
ing doses as previously described [16]: 0.1 μg/min (ACh
1), 1 μg/min (ACh 2) and 10 μg/min (ACh 3). Adenosine
(Ade) was infused at the following rates: 30 μg/min (Ade
1), 150 μg/min (Ade 2) and 300 μg/min (Ade 3). Measure-
ments were performed in the following sequence: BL 1,
ACh 1-3, BL 2, Ade 1-3, and BL 3. At the end of the proto-
col, we acquired a series of images during first-pass per-
fusion using a single-shot GRE-EPI sequence after
intracoronary injection of 0.05 mmol/kg gadopentetate
dimeglumine (Magnevist®, Bayer, Germany) for accu-
rately identifying the LCX perfusion territory and con-
firming the correct position of the intracoronary catheter.
SSFP BOLD-CMR was performed with a T2*-sensitive
cine SSFP sequence as previously described [15]. Scan
parameters were: FOV = 228 × 280 mm; matrix size = 125
× 192; in-plane resolution = 1.8 × 1.6 mm; slice thickness
= 5 mm; TR/TE = 5.8 ms/2.9 ms; flip angle = 90°; readout
bandwidth = 275 Hz/Px; signal averages = 1; the duration
of the typical breath-hold was 15 s. In addition, a seg-
mented multi-echo gradient echo (GRE) sequence was
used (echo train length: 8; TE = 2.6, 4.8, 7.0, 9.3, 11.5, 13.7,
16.0, and 18.2 ms) using a mono-polar readout. K-space
lines from the different echoes were assigned to different
images, and the resulting 8 images were used to generate
a T2* map. Other typical parameters for the multi-echo
GRE sequence were: FOV = 225 × 400 mm; matrix size =
109 × 256; in-plane resolution = 2.1 × 1.6 mm; slice thick-
ness = 10 mm; flip angle = 20°; TR = 120 ms; and typical
breath-hold duration, 16 s. Reproducibility was assessed
by 20 repeated baseline SSFP BOLD-CMR acquisitions in
each of three subjects.
Data Analysis
CMR images were analyzed using certified software
(cmr42, CIRCLE Cardiovascular Imaging Inc., Calgary,
Canada). A region of interest (ROI) was drawn around
the LCX perfusion territory, which was clearly identified
on the perfusion images as contrast was injected from the
infusion catheter placed in the LCX (see Figure 1b). This
ROI was then copied to all other images at the same slice
location with careful adjustments to account for any mis-
matches. Myocardial signal intensity in SSFP BOLD-
CMR images and T2* values were assessed for each proto-
col stage. The SSFP BOLD-CMR signal intensity was cal-
culated for each of the 20 images obtained throughout
the cardiac cycle and then averaged. T2* maps were gen-
erated by fitting a mono-exponential function of TE
through the T2*-weighted signal intensities.
Coronary blood flow was recorded from the Doppler
flow probe (ml/min). Intra-arterial blood pressure was
monitored continuously and the rate-pressure product
(RPP) was calculated from heart rate and systolic pres-
sure.
Statistical Analysis
Continuous variables with normal distribution were sum-
marized as mean ± standard error of the mean. Means atVöhringer et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:20
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each level of drug infusion were analyzed with repeated
measures ANOVA and post-hoc comparisons, using
paired t-tests with Bonferroni adjustments (SPSS 16 for
Macintosh, SPSS Inc, Chicago, USA). Correlation analy-
sis was done (SIGMAPLOT, Windows version 10, Systat
Software, Inc. San Jose, CA, USA) by linear regression
analysis or by regression analysis using a 3-parameter,
exponential-rise equation that asymptotically
approached a maximum.
Sample-size calculation was performed aiming for the
detection of a 200% increase in flow, which was consid-
ered to be relevant in assessment of myocardial perfusion
reserve, with 80% power and 95% significance and based




The drug-infusion protocol was completed and the per-
fusion territory of the LCX was identified in all 7 animals
(examples see Figure 1b and 2d). In three animals, the
adenosine perfusion protocol was shortened because of
difficulties during the surgical or interventional proce-
dure. One of the protocol stages in two of these three ani-
mals and two protocol stages in the third could not be
performed. In one dog, the coronary sinus catheter dislo-
cated after the baseline study and could not be relocated,
so blood gas analysis from the coronary sinus was not
possible. In another dog, a different SSFP BOLD-CMR
sequence was used and only T2* data was included in the
analysis.
Coronary Vasodilation Experiments
Throughout the experiments, there were no significant
changes in heart rate, blood pressure and RPP when com-
pared to baseline (Table 1). Drug-induced vasodilation
significantly increased LCX blood flow, whereas there
was no significant difference between the two repeated
baseline measurements (Table 1). There was a dose-
dependent increase in blood flow, which was accompa-
nied by progressively smaller increases in coronary sinus
oxygen saturation (SvO2). Using the 3-parameter, expo-
nential-rise equation, SvO2 correlated with LCX blood
flow (r2 = 0.84, P  < 0.001) with SvO2approaching 87%
(Figure 3). Mean arterial oxygen saturation was 96.7 ±
1.2%.
Oxygenation-sensitive CMR
SSFP BOLD-CMR consistently provided very good image
quality (Figure 1). Although image quality of T2* maps
was consistent, the images showed distortion and suscep-
tibility artifacts, especially with respect to the infero-lat-
eral wall (Figure 2). Representative images for baseline,
high-dose ACh and/or high-dose Ade are shown in Fig-
ures 1a, c and 2a, b and 2c. After subtracting baseline
image signal intensity, changes of signal intensity were
Figure 1 Examples of BOLD-CMR images a) at baseline; c) during 
infusion of 0.3 mg/min adenosine (Ade 3). The perfusion territory of 
the LCX after intracoronary injection of gadopentetate dimeglumine is 
shown in b) (arrows). Panel d) shows the myocardial signal intensity of 
baseline subtracted from that during adenosine. The higher values in 
the LCX territory reflect the signal intensity increase during in the LCX 
perfusion territory as induced by adenosine injection.
Figure 2 Examples of T2* maps at a) baseline, b) during LCX infu-
sion of 10 μg/min acetylcholine (ACh 3) and c) during infusion of 
0.3 mg/min adenosine (Ade 3). The perfusion territory of the LCX af-
ter intracoronary injection of gadolinium is shown in d) and indicated 
with white arrows.Vöhringer et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:20
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visually apparent (Shown for cine SSFP in Figure 1d). The
baseline reproducibility of myocardial BOLD-CMR signal
intensity in the LCX perfusion territory was excellent
(SEM 0.3%). T2* measurements showed an SEM of 6.8%
at baseline and 1.1% during the protocol.
T o see how well CMR tissue measures of oxygenation
might predict coronary sinus SvO2, we plotted the change
in SvO2 versus myocardial signal intensity (Figure 4) both
expressed as percentages, relative to their respective
baseline values. Coronary sinus SvO2 was linearly and
strongly correlated with myocardial signal intensity in the
SSFP BOLD-CMR images (r2 = 0.74, P < 0.001). T2*
changes were relatively larger but showed increased vari-
ability (r2 = 0.34, p < 0.001).
Discussion
Our in vivo study indicates that changes in BOLD CMR
signal intensity can be used to predict changes in myocar-
dial oxygenation (as indicated by changes in coronary
sinus oxygen saturation) accurately, and with a precision
that promises to make the technique clinically useful.
To our knowledge, this is the first in vivo study to com-
pare oxygenation-sensitive CMR using a state-of-the-art
SSFP sequence against simultaneous coronary venous
blood sampling. Similar studies have been done using T2*
mapping for assessing blood oxygenation[18]. Our results
showed an excellent linear correlation of coronary sinus
oxygen saturation with CMR signal intensity. T2* map-
ping was more sensitive to oxygenation changes but
showed more variability. The fact that BOLD CMR shows
a linear correlation to coronary sinus oxygen saturation is
in agreement with the expected proportionality between
the BOLD effect and the absolute tissue content of deoxy-
genated hemoglobin[13,19,20]. Importantly, a previous
theoretical study by Dharmakumar et al. demonstrated
that the BOLD signal is blood volume-independent[21].
As shown in Figure 3, the relationship between coro-
nary sinus SvO2 and LCX flow can be described using a 3-
parameter, exponential-rise equation. With constant
myocardial oxygen consumption (i.e., constant RPP), cor-
Figure 3 Correlation of absolute oxygen saturation (SvO2) in the 
coronary sinus (CS) and blood flow in the LCX (n = 7). Regression 
lines (dashed lines) are shown. Baseline, Adenosine and acetylcholine 
induced changes in flow represented as circles, squares and triangles, 
respectively. LCX: Left circumflex coronary artery.
Table 1: Physiological parameters at each experimental level
BPsys (mmHg) HR (min-1) RPP (mmHg/
min)
Flow (%) SvO2 (%)
BL1 95.9 ± 2.2 72.0 ± 3.9 6865 ± 276 100.0 ± 0 0 ± 0
Ach1 95.6 ± 2.5 69.9 ± 3.2 6650 ± 258 127.7* ± 4.6 3.6 ± 2.3
Ach2 98.3 ± 1.7 67.3 ± 3.9 6598 ± 263 186.2* ± 13.3 5.3 ± 2.1
Ach3 99.1 ± 2.8 65.6 ± 3.5 6466 ± 282 309.7* ± 29.8 15. 7* ± 0.9
BL2 98.5 ± 3.0 67.2 ± 3.5 6577 ± 232 107.5 ± 5.2 5.2 ± 2.0
Ade1 97.7 ± 2.3 73.0 ± 3.2 7123 ± 304 817.9* ± 122.1 31.3* ± 2.6
Ade2 95.6 ± 4.1 73.4 ± 2.7 7018 ± 410 410.4* ± 64.7 28.9* ± 1.2
Ade3 99.0 ± 1.5 74.0 ± 8.7 7352 ± 981 532.2* ± 56.7 31.5* ± 0.6
BL3 94.6 ± 2.2 71.6 ± 2.3 6769 ± 259 117.2 ± 6.4 4.4 ± 1.4
p < 0.05 compared to baseline
Mean values and SEM for systolic blood pressure (sysBP), heart rate (HR), rate-pressure product (RPP), flow in the left circumflex coronary 
artery (flow) relative to baseline 1 and change in coronary sinus oxygen saturation (SvO2) from baseline 1 at the different experimental levels 
(BL 1-3: baseline, ACh 1-3: intracoronary acetylcholine infusion/increasing doses, Ade 1-3: intracoronary adenosine infusion/increasing doses; 
detailed drug doses in the text). *: p < 0.05 vs. baseline (BL1).Vöhringer et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:20
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onary sinus SvO2 approached an asymptotic value (87%)
as the LCX was over-perfused with near-saturated (97%)
arterial blood under the influence of coronary vasodila-
tors (ACh and Ade).
We chose to use both acetylcholine and adenosine to
demonstrate that this technique was sensitive to both
endothelium-dependent and -independent vasodilation.
The same relationship between myocardial BOLD-CMR
signal intensity, coronary blood flow, and SvO2  was
observed for ACh- and Ade-induced flow changes (see
Figures 3 and 4). This also excludes a significant impact of
nitric oxide on myocardial oxygen consumption in acetyl-
choline-induced vasodilation, as previously specu-
lated[22]. Therefore, SSFP BOLD-CMR appears suitable
for studies with both, endothelium-dependent as well as
endothelium-independent vasodilation.
I n  o u r  s t u d y ,  w e  u n c o u p l e d  m y o c a r d i a l  o x y g e n  c o n -
s u m p t i o n  f r o m  m y o c a r d i a l  b l o o d  f l o w  b y  i n f u s i n g  a n
intracoronary vasodilator that increased blood flow but
not heart rate, blood pressure, or RPP (Table 1), which is
a surrogate marker for myocardial oxygen consump-
tion[23]. Thus, our model allowed for a selective assess-
ment of perfusion-induced changes while keeping
myocardial oxygen consumption stable.
Potential for detection of myocardial ischemia
Obviously, it would have been of great interest to be able
to follow this relationship into the ischemic range but,
unfortunately, our attempts to limit LCX flow were not
successful in this experimental preparation. However, the
linearity and highly correlated nature of the relation
between SvO2  and CMR signal intensity suggest that
some extrapolation into the ischemic range would be jus-
tified. Based on the control values of LCX flow and the
correlations we obtained (see Figure 3), we estimated that
the normal average value of coronary sinus SvO2 at base-
line was 50% and that the maximum value was ~90%.
Accordingly, we used these values (see right-hand ordi-
nate in Figure 4) to express SvO2 relatively, as the change
from this control value in % SvO2. Thus, we were able to
plot changes in coronary sinus SvO2 versus relative value
of BOLD CMR signal intensity (Figure 4) throughout the
range of LCX flows that we observed and extrapolate into
the ischemic ranges (note the extrapolation of the linear
regression line). Further experimental and clinical studies
should be undertaken to test the accuracy and utility of
BOLD-CMR in the presence of myocardial ischemia.
Comparison to Previous Studies
The effects of ACh and Ade on coronary flow shown in
this study are within the range of previously reported
studies[16,17,24]. Foltz et al. found similar changes in
coronary venous oxygen saturation by intracoronary ade-
nosine infusion in the porcine LAD[17]. The correspond-
ing changes in T2 they found during maximal vasodilation
were in the range of the T2* changes we observed,
although our T2* mapping technique did not provide the
same consistency. This may be due to the differences in
MR techniques and/or differences in coronary territories
assessed (LAD vs. LCX). In our protocol, we included the
inferolateral wall, which is particularly susceptible for off-
resonance artifacts in BOLD-sensitive CMR[4]. In a simi-
lar experimental approach, Fieno et al. could also demon-
strate a close correlation of myocardial perfusion and
BOLD-sensitive CMR[11]. They used a different BOLD-
sensitive CMR technique, which resulted in relatively
higher SI changes (up to 30%), which, however, were lin-
early correlated to myocardial flow, whereas we found an
exponential correlation that matches the T2* and SvO2
changes. We believe that this difference might be
explained by T2 and T1 interference in T2-prepared SSFP
imaging since the acquisition follows a T2-preparared
SSFP imaging since the acquisition follows a T2-prepara-
tion period followed by signal readout during which T1
recovery is also expected to occur. Finally, in our method,
the relatively short breath hold of less than 15 seconds is
an advantage.
Clinical Implications
Besides its apparent utility for clinical research, BOLD-
CMR appears particularly useful for the clinical assess-
ment of coronary perfusion reserve as used for the detec-
tion of relevant coronary artery stenoses. Since BOLD-
Figure 4 Linear correlation of SvO2 changes from baseline values 
versus myocardial BOLD-CMR signal intensity relative to baseline 
(n = 6). Regression lines (dashed lines) are shown. Baseline, adenosine 
and acetylcholine induced changes in flow represented as circles, 
squares and triangles, respectively. Figure 4 includes the results of the 
analyses of extrapolated lines. See text. LCX = left circumflex coronary 
artery.Vöhringer et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:20
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CMR provides a biomarker (Hb oxygenation) instead of
surrogate markers, it may overcome many limitations of
currently used diagnostic tools. F urthermore, it can be
applied as part of a comprehensive CMR study including
cardiac morphology, function, coronary anatomy, isch-
emia, and tissue pathology.
Limitations
The critical element in our experimental design is that
SvO2 should reflect the degree of oxygenation of the LCX
myocardium that we evaluated by BOLD SI. We cannot
rule out the possibility that there was some admixture by
blood draining from areas other than the LCX-perfused
myocardium. However, the LCX is the dominant coro-
nary artery in the dog and its course parallels that of the
coronary sinus. Furthermore, as pharmacological vasodi-
latation increased LCX flow, SvO2 approached 87% --
only 10% below arterial saturation -- suggesting that LCX
drainage was overwhelmingly dominant.
Conclusions
Oxygenation-sensitive CMR using a T2*-sensitive SSFP
BOLD sequence allows for non-invasive assessment of
changes of myocardial oxygenation in vivo; specifically
changes in BOLD signal are impressively proportional to
changes in coronary sinus oxygen saturation. Further
studies to assess the feasibility and accuracy of this tech-
nique in clinical settings are warranted.
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